Admetsys Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Corporate
  • Investors
  • 12

Admetsys General Information

Description

Developer of a blood-sugar management system designed to control blood sugar in diabetes patients. The company's system uses a standard IV line, which draws a small blood sample every few minutes, from which it measures glucose electrochemically and returns the blood back to the patient and has also developed first-of-its-kind artificial pancreas, enabling hospitals to more effectively control blood glucose levels and alleviate some of the stresses associated with diabetic care in the hospital environment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Therapeutic Devices
Biotechnology
Primary Office
  • 21 Drydock Avenue
  • 6th Floor
  • Boston, MA 02210
  • United States
+1 (800) 000-0000

Admetsys Timeline

2017201820192020
Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Admetsys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Corporate 06-Jun-2017 00.000 Completed Clinical Trials - General
10. Early Stage VC 27-Apr-2017 00000 00.000 Completed Clinical Trials - General
9. Accelerator/Incubator 28-Jun-2016 00.000 Completed Clinical Trials - General
8. Accelerator/Incubator 08-Mar-2016 000 00.000 Completed Clinical Trials - General
7. Accelerator/Incubator 29-Jul-2015 000.00 Completed Clinical Trials - General
6. Accelerator/Incubator 14-Jul-2015 000.00 Completed Clinical Trials - General
5. Accelerator/Incubator 24-Jun-2015 000.00 Completed Clinical Trials - General
4. Grant 15-Apr-2015 00.00 000.00 Completed Clinical Trials - General
3. Accelerator/Incubator 09-Mar-2015 $37.4K Completed Clinical Trials - General
2. Accelerator/Incubator 01-Dec-2014 $37.4K $37.4K Completed Clinical Trials - General
To view Admetsys’s complete valuation and funding history, request access »

Admetsys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a blood-sugar management system designed to control blood sugar in diabetes patients. The company's system
Monitoring Equipment
Boston, MA
7 As of 2016
00.000
000000000000 00.000

00000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
0000000000 000000000
Malvern, PA
0000 As of 0000
0.00 0000-00-00
000000000000

0000000

te velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident
0000000000 000000000
San Diego, CA
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Admetsys Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LifeScan Private Equity-Backed Malvern, PA 0000 000000000000
0000000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000000 Formerly VC-backed Rydalmere, Australia 00 000.00 000000000 000.00
00000000 00000 Private Equity-Backed Tampa, FL 000.00 000000000000 000.00
0000000 Corporate Backed or Acquired Ängelholm, Sweden 000 000000&0
To view Admetsys’s complete competitors history, request access »

Admetsys Executive Team (3)

Name Title Board Seat Contact Info
Jeffrey Valk Co-Founder & Chief Executive Officer
Glenn Robertelli Co-Founder & Chief Operating Officer
Tim Valk MD Chief Scientist
To view Admetsys’s complete executive team members history, request access »

Admetsys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Admetsys Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
T1D Exchange Corporation Minority 000 0000 000000 0
Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies University Minority 000 0000 000000 0
TiE-Boston Accelerator/Incubator 000 0000 000000 0
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
DreamIt Ventures Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »